Results 1-8 of 8 for drugs speaker:Mal O'Hara

Committee on Drugs Use: Decriminalisation, Depenalisation, Diversion and Legalisation of Drugs: Discussion (Resumed) (9 Jul 2024)

Mal O'Hara: Ms Wilson almost pre-empted my next question. I wanted to talk about drug testing. She referred to the increased toxicity of substances. What is the regime or scheme around testing? Is there any sense of diversionary tactics? She said the police have limited powers with decriminalisation. What would she suggest might be an appropriate diversionary tactic?

Committee on Drugs Use: Decriminalisation, Depenalisation, Diversion and Legalisation of Drugs: Discussion (27 Jun 2024)

Mal O'Hara: Deputy Hourigan referred to this already referred to potency and the potential for testing drugs. Which avenue provides us with the best opportunity in this regard?

Committee on Drugs Use: Decriminalisation, Depenalisation, Diversion and Legalisation of Drugs: Discussion (27 Jun 2024)

Mal O'Hara: Apologies. I had to nip out to the Seanad. I have a question which might be difficult to answer. Obviously this is a shared island. Does any of the international evidence around a divergence in drug policy approaches between states with a permeable border where people cross freely, where supply markets are all-island-based, and so on, indicate what impact changes that we were to make in...

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Mal O'Hara: ...in comparison with other European countries. How does that benchmark against others? Some of the key actions being taken were mentioned. Are there inhibitors to good practice in the Misuse of Drugs Act and, if so, what are they?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Mal O'Hara: What are the barriers to international good practice caused by the Misuse of Drugs Act? Perhaps it is a question for the Department of Justice.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Mal O'Hara: When we speak about innovative approaches, we mean health-led and human rights-compliant approaches. I firmly believe the Misuse of Drugs Act inhibits us from taking some of those approaches. What international evidence do we have to suggest things we cannot do because of the Misuse of Drugs Act?

Joint Oireachtas Committee on the Implementation of the Good Friday Agreement: All-Island Economy: Discussion (Resumed) (23 May 2024)

Mal O'Hara: ...failed to deal with legacy, how we have the poorest mental health in the UK in the North, wee have underspent on mental health services, how we have a high rate of suicide, how we have the biggest drug debts for men of a certain population outside of Scotland in western Europe, and those health inequalities. I want to tease out the issues around intergenerational trauma and that idea of a...

Seanad: An tOrd Gnó (Atógáil) - Order of Business (Resumed) (24 Apr 2024)

Mal O'Hara: ...In my inauguration speech, I said that I wish to be a Senator for all and that I want to amplify voices in the North. The voices I will talk about today are those of people who have experienced drug deaths and of their families. Yesterday, the Northern Ireland Assembly debated a motion on drug deaths, but it was poor and vacuous and did not address the root cause of the issues or use...